Application
A. Western blot analysis on Jurkat cell lysate using anti-Phospho-ZAP70 (pY292) RabMAb (Cat. #AJ1824c), 1:10,000 dilution. Cells were either (A) untreated (B) treated with pervanadate
Application
B. Flow cytometric analysis of permeabilized Jurkat cells, untreated (green) or pervanadate -treated (red) using anti- Cbl RabMAb (Cat. #AJ1824c), and pervanadate-treated Jurkat cells using the same antibody preincubated with phospho- ZAP70 (Tyr 292) peptide (blue) or non-phospho- ZAP70 (Tyr 292).